TM9SF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.714210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.894400E-01
Normal-vs-Stage2
1.458220E-01
Normal-vs-Stage3
5.378200E-01
Normal-vs-Stage4
1.667610E-01
Stage1-vs-Stage2
6.512200E-01
Stage1-vs-Stage3
4.972000E-01
Stage1-vs-Stage4
5.386000E-01
Stage2-vs-Stage3
4.751000E-01
Stage2-vs-Stage4
3.545400E-01
Stage3-vs-Stage4
2.546800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.024000E-01
Normal-vs-AfricanAmerican
1.324760E-01
Normal-vs-Asian
7.912000E-02
Caucasian-vs-AfricanAmerican
6.733000E-01
Caucasian-vs-Asian
4.558600E-01
AfricanAmerican-vs-Asian
8.972800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.695760E-01
Normal-vs-Female
1.853840E-01
Male-vs-Female
9.041600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.117200E-01
Normal-vs-Age(41-60Yrs)
1.117210E-01
Normal-vs-Age(61-80Yrs)
1.953610E-01
Normal-vs-Age(81-100Yrs)
2.861200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.698160E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.778400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.557200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.697000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.991600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.548400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.524800E-01
Normal-vs-Daily Drinker
3.090000E-01
Normal-vs-Weekly Drinker
3.369600E-01
Normal-vs-Occasional Drinker
7.111600E-02
Normal-vs-Social Drinker
3.037000E-01
Non Drinker-vs-Daily Drinker
8.899800E-01
Non Drinker-vs-Weekly Drinker
9.002000E-01
Non Drinker-vs-Occasional Drinker
6.978200E-02
Non Drinker-vs-Social Drinker
7.831400E-01
Daily Drinker-vs-Weekly Drinker
9.897600E-01
Daily Drinker-vs-Occasional Drinker
2.074800E-01
Daily Drinker-vs-Social Drinker
9.144600E-01
Weekly Drinker-vs-Occasional Drinker
2.706000E-01
Weekly Drinker-vs-Social Drinker
9.341200E-01
Occasional Drinker-vs-Social Drinker
3.001000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.806300E-02
Normal-vs-Grade 2
2.040000E-02
Normal-vs-Grade 3
3.336200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.249000E-01
Grade 1-vs-Grade 3
3.556600E-01
Grade 1-vs-Grade 4
8.806300E-02
Grade 2-vs-Grade 3
8.865800E-01
Grade 2-vs-Grade 4
2.040000E-02
Grade 3-vs-Grade 4
3.336200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.969400E-01
Normal-vs-NonDiabetic
1.625650E-01
Diabetic-vs-NonDiabetic
6.742400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.948000E-02
Normal-vs-NoPancreatitis
1.988630E-01
Pancreatitis-vs-NoPancreatitis
8.248800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.704770E-01
Normal-vs-N1
1.678640E-01
N0-vs-N1
5.621000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.670300E-02
Normal-vs-TP53-NonMutant
1.823600E-01
TP53-Mutant-vs-TP53-NonMutant
3.152200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
